MSc (Advanced Cell and Gene Therapy)
Overview
The MSc in Advanced Cell and Gene Therapy is a part-time programme which comprises of a work-related research project carried out primarily in industry or academic research laboratory over six-month period during one academic year.
Postgraduate Diploma in Advanced Cell and Gene Therapy
To progress to the Master of Science in Advanced Cell and Gene Therapy students must pass modules to the value of 60 credits in the Postgraduate Diploma in Advanced Cell and Gene Therapy and achieve an aggregate of at least 50% across all modules to the value of 60 credits.
The MSc in Advanced Cell and Gene Therapy consists of:
- BC6014 Research Dissertation in Advanced Therapy Medicinal Products (30 credits), and
- 60 credits from the Postgraduate Diploma in Advanced Cell and Gene Therapy
Programme Requirements
For information about modules, module choice, options and credit weightings, please go to Programme Requirements.
Programme Requirements
| Code | Title | Credits |
|---|---|---|
| Year 1 | ||
| Postgraduate Diploma in Advanced Cell and Gene Therapy | 60 | |
| Year 2 | ||
| Students take 30 credits as follows: | ||
| Core Modules | ||
| BC6014 | Research Dissertation in Advanced Therapy Medicinal Products | 30 |
| Total Credits | 90 | |
Examinations
Full details and regulations governing Examinations for each programme will be contained in the Marks and Standards Book and for each module in the Book of Modules.
Programme Learning Outcomes
Programme Learning Outcomes for the MSc (Advanced Cell and Gene Therapy) (NFQ Level 9, Major Award)
On successful completion of this programme, students should be able to:
11-1
Discuss the theory and concepts that define and differentiate cell and gene therapy and the wider scientific and cultural contexts in which they are being developed and applied.
1-2
2
Define the underlying principles of cell and gene therapy, including the molecular mechanisms involved in gene regulation, gene delivery, and cell-based therapies.
1-3
3
Discuss strategies available for developing a vaccine and explain the significance of critical antigens, immunogens, and adjuvants in developing effective vaccines.
1-4
4
Understand the regulatory landscape surrounding cell and gene therapy development and will be equipped to navigate the complex regulatory requirements.
1-5
5
Recognize the ethical considerations involved in developing and administering cell and gene therapies, including issues related to patient consent, privacy, and access.
1-6
6
Apply laboratory techniques, such as mammalian cell culture, bioassays, gene editing, and genome sequence analysis, that are used in cell and gene therapy research.
1-7
7
Work in interdisciplinary teams with scientists and regulatory experts to advance the field of cell and gene therapy.
1-8
8
Demonstrate the ability to critically discuss and reflect on ethical and social aspects of using immune, gene or cell therapy.
1-9
9
Complete a body of independent research in an industry-relevant area and present research findings in a minor dissertation.